Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans

Author: Diamond S.   Freitag F.   Feoktistov A.   Nissan G.  

Publisher: Springer Publishing Company

ISSN: 1129-2369

Source: The Journal of Headache and Pain, Vol.8, Iss.1, 2007-02, pp. : 13-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content